News

A warm welcome to the newest member of the SPARK global community. SPARK the Midlands (Birmingham,…

Welcome to all new SPARK-BIH teams and a big thank you to all the 2023 Call participants

Within the new NDR Podcast episode, Prof. Schülke presented their drug discovery for mitochondrially inherited Leigh Syndrome (MILS).

The NeuroCure/SPARK-supported team Myalink (Dr. Sophie Lehnerer and Dr. Maike Stein) presented their project within BERLIN BRAINS: Rare meets Care - how digital medicine opens new perspectives for rare diseases.

Building on our previous experience with this format, NeuroCure and SPARK-BIH organized a medical Design Thinking workshop in order to support innovational project ideas from the NeuroCure community. The two-day workshop took place in the innovative location ‘Digital Labs’ from the BIH.

At this year's BioVaria in Munich at the end of April, there was a session for very early start-up…

A SPARK-BIH funded project on the development of an innovative tumor-specific immunotherapy for the treatment of B-cell lymphomas has successfully been awarded a follow-on BMBF grant for a first-in-human clinical trial.

Two SPARK-BIH funded teams network with investors and the life science industry at the international JPM BIO Partnering Event.

Dr. Angelika Vlachou, Principal at High-Tech Gründerfonds (HTGF), supported 25 translational SPARK project teams with a dedicated hands-on Pitch Training Workshop.

SPARK-BIH and NeuroCure organized a second Design Thinking workshop.